Search the Newsroom
Filter By
News Type
Showing 81 - 90 of 233 results
Children’s Hospital of Philadelphia Receives $650,000 Donation to Advance Brain Tumor Research and Discoveries Within the Children’s Brain Tumor Network
The Lilabean Foundation’s support will accelerate pace of translational research, discovery of new treatments for children and young adults with brain tumors.
The Cancer Center Celebrates Women’s History Month
As we recognize women’s contributions to history during March, meet a few of the inspiring women on the Cancer Center’s team.
CHOP Study Shows Chemotherapy-Resistant Neuroblastoma Cells Have More Active Inflammatory Sensing and Signaling
CHOP researchers have found that chemo-resistant mesenchymal cells in neuroblastoma might be vulnerable to immunotherapy.
CHOP/Penn Study Shows CAR-T Cells Remain Active a Decade After Infusion
A new study in Nature has documented the longest persistence of CAR T cell therapy to date.
Q&A with Dr. Tracey Jubelirer
Tracey Jubelirer, MD, is the Medical Director of the inpatient oncology unit at the Middleman Family Pavilion at Children’s Hospital of Philadelphia, King of Prussia.
CHOP Researchers Define a 3-Tiered Molecular Classification of Pediatric Differentiated Thyroid Cancer, where Fusion Oncogenes Predict the Most Invasive Behavior
CHOP researchers have defined a 3-tiered molecular classification of pediatric differentiated thyroid cancer, where fusion oncogenes predict the most invasive behavior.
Yoga and Oncology
To help children through cancer treatment, yoga therapy is offered at our Voorhees and King of Prussia Specialty Care Centers.
Researchers Point to Need for Implementation Science in Pediatric Oncology
CHOP researchers have found that implementation science is underused in pediatric oncology and call for more research in this area to improve patient care.
Aberrant Splicing of CD22 in Acute Lymphoblastic Leukemia Underlies Resistance to Immunotherapy
Aberrant splicing leads to downregulation of CD22 in pediatric B-ALL, rendering malignant cells resistant to the effects of CD22-directed immunotherapies.
CHOP Researchers Find Possible Increased Tumor Risk in Some Patients with Beckwith-Wiedemann Spectrum
Researchers have unlocked patterns to improve the diagnosis of the most common epigenetic childhood cancer disorder.